■ The diagnosis and treatment of glaucoma
Alexander K. Schuster, Carl Erb, Esther M. Hoffmann, Thomas Dietlein, Norbert Pfeiffer
Dtsch Arztebl Int.2020, vol 117(13): 225–234
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196841/
■ Current medical therapy and future trends in the management of glaucoma treatment
Barbara Cvenkel, Miriam Kolko
J Ophthalmol.2020; 2020: 6138132
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391108/
■ Sustained-release drug delivery system for the treatment of glaucoma
Natasha P. Kesav, Cara E. Capitena Young, Monica K. Ertel et al
Int J Ophthalmol.2021; vol 14(1): 148–159.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790669/
■ Microinvasive glaucoma surgery: a review of Schlemm´s canal-based procedures
Joanna Konopińska, Katarzyna Lewczuk, Joanna Jabłońska et al
Clin Ophthalmol.2021; vol 15: 1109–1118
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961128/
■ Corneal hysteresis as a biomarker of glaucoma: current insignts
Larae Zimprich, Jacob Diedrich, Adam Bleeker, Justin A Schweitzer
Clin Ophthalmol.2020; vol 14: 2255–2264
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429407/
■ Challenges in the complex management of post-keratoplasty glaucoma
Lisa-Marie Anders, Zisis Gatzioufas, Matthias C. Grieshaber
Ther Adv Ophthalmol.2021, vol 13: 25158414211031397
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295943/
■ Surgical and perioperative considerations for the treatment of cataract in eyes with glaucoma: a literature review
Kleonikos Tsakiris, George Kontadakis, Panagiotis Georgoudis et al
J Ophthalmol.2021; 2021: 5575445.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093062/
■ Neuroinflammatory mechanisms of mitochondrial dysfunction and neurodegeneration in glaucoma
Joao N. Duarte
J Ophthalmol.2021; 2021: 4581909.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064803/
■ Carotenoids in the management of glaucoma: a systematic review of the evidence
Drake W. Lem, Dennis L. Gierhart, Pinakin Gunvant Davey
Nutrients.2021, vol 13(6): 1949
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228567/
■ Energy metabolism in the inner retina in health and glaucoma
Hanhan Liu, Verena Prokosch
Int J Mol Sci.2021, vol 22(7): 3689
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036449/
■ Psychopharmacological treatment, intraocular pressure and the risk of glaucoma: a review of literature
Adela Magdalena Ciobanu, Vlad Dionisie, Cristina Neagu, et al
J Clin Med.2021, vol 10(13): 2947
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269427/
■ Changes in corneal thickness after vitrectomy – implications for glaucoma practice
Lisika Gawas, Aparna Rao
PLoS One.2021; vol 16(4): e0249945.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059830/
■ Confocal microscopy and anterior segment optical coherence tomography imaging of the ocular surface and bled morphology in medically and surgically treated glaucoma patients: a review
Carmela Carnevale, Ivano Riva, Gloria Roberti, et al
Pharmaceuticals (Basel) 2021, vol 14(6): 581
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234834/
■ Selective laser trabeculoplasty (SLT) performed by optometrists for patients with glaucoma and ocular hypertension: a scoping review
Lee Jones, Evgenia Konstantakopoulou, Gus Gazzard
BMJ Open Ophthalmol.2021; vol 6(1): e000611.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957126/
■ The impact of artificial intelligence in the diagnosis and management of glaucoma
Eileen L. Mayro, Mengyu Wang, Tobias Elze, Louis R. Pasquale
Eye (Lond) 2020, vol 34(1): 1–11
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002653/
■ A review of systemic medications that may modulate the risk of glaucoma
Annie Wu, Anthony P. Khawaja, Louis R. Pasquale, Joshua D. Stein
Eye (Lond) 2020, vol 34(1): 12–28.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002596/
■ Clinical implications of recent advances in primary open-angle glaucoma genetics
Hélène Choquet, Janey L. Wiggs, Anthony P. Khawaja
Eye (Lond) 2020, vol 34(1): 29–39
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002426/
■ Optical coherence tomography and optical coherence tomography angiography in glaucoma: diagnosis, progression, and correlation with functional tests
Giacinto Triolo, Alessandro Rabiolo
Ther Adv Ophthalmol.2020, vol 12: 2515841419899822
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970474/
■ Promissing therapeutic drug delivery systems for glaucoma: a comprehensive review
Rohan B. Singh, Parul Ichhpujani, Sahil Thakur, Sumeet Jindal
Ther Adv Ophthalmol.2020, vol 12: 2515841420905740
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074511/
■ Has the EAGLE landed for the use of clear lens extraction in angle-closure glaucoma? And how should primary angle-closure suspects be treated?
Luke Tanner, Gus Gazzard, Winifred P. Nolan, Paul J. Foster
Eye (Lond) 2020, vol 34(1): 40–50
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002615/
■ Recent advances in anterior chamber angle imaging
Natalia Porporato, Mani Baskaran, Rahat Husain, Tin Aung
Eye (Lond) 2020, vol 34(1): 51–59
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002644/
■ Treatment choices for newly diagnosed primary open angle and ocular hypertension patients
Anurag Garg, Gus Gazzard
Eye (Lond) 2020, vol 34(1): 60–71
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002706/
■ New glaucoma medications: latanoprostene bunod, netarsudil, and fixed combination netardudil-latanoprost
Nikki A. Mehran, Sapna Sinha, Reza Razeghinejad
Eye (Lond) 2020, vol 34(1): 72–88
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002400/
■ Care pathways for glaucoma detection and monitoring in the UK
Robert A. Harper, Patrick J. G. Gunn, Paul G. D. Spry et al
Eye (Lond)2020, vol 34(1): 89–102
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002668/
■ Advanced glaucoma at diagnosis: current perspectives
Alan Kastner, Anthony J. King
Eye (Lond) 2020, vol 34(1): 116–128
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002722/
■ Heavy metal toxicity and the aetiology of glaucoma
Sarath Vennam, Stelios Georgoulas, Anthony Khawaja et al
Eye (Lond) 2020, vol 34(1): 129–137
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002597/
■ How do different lighting conditions affect the vision and quality of life of people with glaucoma? A systematic review
Jamie Enoch, Lee Jones, Deanna J. Taylor, et al
Eye (Lond) 2020, vol 34(1): 138–154
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002549/
■ Home monitoring for glaucoma
Jemaima Che Hamzah, Qëndresë Daka, Augusto Azuara-Blanco
Eye (Lond) 2020, vol 34(1): 155–160
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002638/
■ Systematic review and randomized controlled trials on open angle glaucoma
Richard Wormald, Gianni Virgili, Augusto Azuara-Blanco
Eye (Lond) 2020, vol 34(1): 161–167
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002425/
■ Intra-operative optical coherence tomography in glaucoma surgery – a systematic review
Bryan C. H. Ang, Sheng Yang Lim, Syril Dorairaj
Eye (Lond) 2020 vol 34(1): 168–177
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002696/
■ The role of intracranial pressure in glaucoma and therapeutic implications
Alex J. Baneke, James Aubry, Ananth C. Viswanathan, Gordon T. Plant
Eye (Lond) 2020, vol 34(1): 178–191
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002772/
■ The use of generic medications for glaucoma
Andrew J. Tatham
J Ophthalmol.2020; 2020: 1651265
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166283/
■ Influence of cost of care and adherence in glaucoma management: an update
Frances Meier-Gibbons, Marc Töteberg-Harms
J Ophthalmol 2020; 2020: 5901537
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168718/
■ Innovative IOP-independet neuroprotection and neuroregeneration strategies in the pipeline for glaucoma
James C. Tsai
J Ophthalmol.2020; 2020: 9329310
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7512103/
■ Prospective studies of minimally invasive glaucoma surgeries: systematic review and quality assessment
Jullia A Rosdahl, Divakar Gupta
Clin Ophthalmol.2020; vol 14: 231–243
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986542/
■ XEN gel stent: a comprehensive review on its use as a treatment option for refractory glaucoma
Antonio M Fea, Georges M Durr, Paola Marolo et al
Clin Ophthalmol.2020; vol 14: 1805–1832
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335291/
■ Minimally invasive surgery in mild-to-moderate glaucoma patients in Italy: Is it time to change?
Ciro Costagliola, Mario Sbordone, Stefano Gandolfi, et al
Clin Ophthalmol.2020; vol 14: 2639–2655
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500840/
■ The Baerveldt glaucoma drainage device: efficacy, safety, and place in therapy
Huub J Poelman, Roger C W Wolfs, Wishal D Ramdas
Clin Ophthalmol 2020; vol 14: 2789–2797
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522304/
■ Neurodegeneration in Alzheimer´s disease and glaucoma: overlaps and missing links
Sagnik Sen, Rohit Saxena, Manjari Tripathi, Deepti Vibha, Rebika Dhiman
Eye (Lond) 2020, vol 34(9): 1546–1553.
https://www.nature.com/articles/s41433-020-0836-x
■ Neuroinflammation in primary open-angle glaucoma
Stefania Vernazza, Sara Tirendi, Anna Maria Bassi, Carlo Enrico Traverso, Sergio Claudio Saccà
J Clin Med.2020, vol 9(10): 3172
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601106/
■ Glaucoma: Organizações Médicas (Glaucoma: Medical Organizations)
Arquivo Blog Internet Médica – agosto 2021
https://internetmedica.com.br/glaucoma-organizacoes-medicas-glaucoma-medical-organizations/
■ Glaucoma: Mednews II
Arquivo Blog Internet Médica – agosto 2021
https://internetmedica.com.br/glaucoma-mednews-ii/
■ Glaucoma
D Gupta, P P Chen
Am Fam Physician 2016, vol 93 (8): 668-674
https://www.aafp.org/afp/2016/0415/p668.html
■ Dr Paulo Fernando Leite
Cardiologia/Prevenção Cardiovascular
Consultório: Rua Padre Rolim 815/sala 601 – Belo Horizonte/MG/Brasil
Tel: 33245518
CRMMG: 7026
Email: pfleite1873@gmail.com
Blog Internet Médica – www.internetmedica.com.br
Data: agosto 2021
